Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial - Concepedia

Concepedia

Publication | Open Access

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial

DOI Full Paper Access

95

Citations

52

References

2023

Year

Moritz Hundertmark, Amanda Adler, Charalambos Antoniades, Ruth L. Coleman, Julian L. Griffin, Rury R. Holman, Hanan Lamlum, Jisoo Lee, Daniel Massey, Jack J. Miller,

Abstract

gov; Unique identifier: NCT03332212.

References

	Year	Citations
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Theresa A. McDonagh, Marco Metra, Marianna Adamo, European Heart Journal	2021	12K
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Bernard Zinman, Christoph Wanner, John M. Lachin, New England Journal of Medicine	2015	11.6K
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, New England Journal of Medicine	2019	6.4K
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Milton Packer, Stefan D. Anker, Javed Butler, New England Journal of Medicine	2020	4.7K
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation	2022	1.8K
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure Deepak L. Bhatt, Michael Szarek, Philippe Gabríel Steg, New England Journal of Medicine	2020	1.7K
pcaMethods—a bioconductor package providing PCA methods for incomplete data Wolfram Stacklies, Henning Redestig, Matthias Scholz, Bioinformatics	2007	1.2K
Cardiac Energy Metabolism in Heart Failure Circulation Research	2021	1.2K
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Journal of Clinical Investigation	2014	1.1K
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis Ele Ferrannini, Michael Mark, Eric Mayoux Diabetes Care	2016	948

Page 1